MEDI-FIRST
NDC 71927-019, Benzalkonium Chloride, Lidocaine, cream, from Orazen Inc.
- Product NDC
- 71927-019
- Status
- Listed
- Labeler
- Orazen Inc
- Dosage form
- CREAM
- Route
- TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M017
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71927-019 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LIDOCAINE HYDROCHLORIDE5 mg/g
- BENZALKONIUM CHLORIDE1.3 mg/g
Pharmacologic classes
Amide Local Anesthetic [EPC]; Amides [CS]; Antiarrhythmic [EPC]; Local Anesthesia [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71927-019-02 | 71927001902 | 25 POUCH in 1 BOX (71927-019-02) / .9 g in 1 POUCH (71927-019-01) |
| 71927-019-03 | 71927001903 | 25 POUCH in 1 BOX (71927-019-03) / .9 g in 1 POUCH (71927-019-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 71927-019 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71927-019 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71927-019. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.